You are here:
glivec
#

glivec

glivec - Total results - 14

Novartis patent row: US 'concerned' over India's patent norms, innovation

Updated : May 02, 2013

By : hidden hidden

Category : Business

Novartis patent row: US 'concerned' over India's patent norms, innovation

Raising questions over innovation climate in India, the US has said the recent decision by India's Supreme Court to prohibit patent of Novartis' cancer drug Glivec could "preclude issuance of a patent" in the country. #India #WhyNow #Drugs #Innovation #Patent #Pharma #Novartis #glivec
Merck vs Glenmark: Another instance of MNC highhandedness

Updated : Apr 11, 2013

By : FP Editors

Category : Business

Merck vs Glenmark: Another instance of MNC highhandedness

The court case is an attempt by the Big Pharma to pressure the government to not give marketing approval for generic versions of drugs that have been accorded patent in India. #HowThisWorks #Glenmark #glivec #Merck
How the Indian judgment on Novartis will reverberate across the world

Updated : Apr 03, 2013

By : hidden hidden

Category : World

How the Indian judgment on Novartis will reverberate across the world

A systematic campaign organised by major pharma companies against India is already underway for alleged lack of intellectual property protection. #HowThisWorks #US #Cipla #patents #intellectual property rights #Novartis #glivec
From Apple to Novartis: Why some patents deserve to die

Updated : Apr 02, 2013

By : R Jagannathan

Category : Business

From Apple to Novartis: Why some patents deserve to die

Patents are meant to be given for genuine inventions. Not for minor tweaks. This is why Novartis lost its case with Glivec. #Apple #patents #Novartis #glivec #Rubberbanding
Novartis judgment: Let's make research a priority, rest will follow

Updated : Apr 02, 2013

By : G Pramod Kumar

Category : Business

Novartis judgment: Let's make research a priority, rest will follow

Our academic and research institutions have to make research a priority and the government has to liberally fund them. The bottomline of the Glivec and recent experiences is simple - we should get our priorities right. The rest will fall in place.

#Drugs #R&D #TheExplainer #Novartis #big pharma #glivec
Manmohan Singh must learn from the Novartis judgement

Updated : Apr 02, 2013

By : G Pramod Kumar

Category : India

Manmohan Singh must learn from the Novartis judgement

The Prime Minister should evaluate his support for a free trade agreement with the EU, or at least make it more transparent before it is agreed upon. #HowThisWorks #Supreme Court #EU #Free trade agreement #Novartis #glivec
Novartis patent case: Five facts about the cancer drug Glivec

Updated : Apr 02, 2013

By : FP Staff

Category : Business

Novartis patent case: Five facts about the cancer drug Glivec

Glivec has been a major breakthrough invention of the 20th century for the treatment of cancer. Here are five things you should know about the drug. #didyouknow #Novartis #cancer drug #glivec
Why the rejection of Novartis patent plea is a huge victory for India

Updated : Apr 02, 2013

By : G Pramod Kumar

Category : Breaking Views

Why the rejection of Novartis patent plea is a huge victory for India

Had Novartis won the case, big pharma would have indulged in reckless “ever-greening” of drugs keeping life-saving drugs out of the reach of most people in India. #India #Supreme Court #InMyOpinion #Drugs #Novartis #glivec
Will not invest in R&D of medicines in India: Novartis chairman

Updated : Apr 01, 2013

By : FP Staff

Category : Business

Will not invest in R&D of medicines in India: Novartis chairman

Drug major Novartis warned that Supreme Court's rejection of its patent plea for cancer drug Glivec will discourage future innovation in India and pointed out that the company has never been granted an original patent for Glivec in the country. #Supreme Court #TheySaidIt #Novartis #cancer drug #glivec #Patent Claim
Novartis patent case: Section 3(d) of Indian Patent Act explained

Updated : Apr 01, 2013

By : FP Staff

Category : Business

Novartis patent case: Section 3(d) of Indian Patent Act explained

This section states that inventions that are a mere "discovery" of a "new form" of a "known substance" and do not result in increased efficacy of that substance are not patentable. #didyouknow #Cipla #cancer drugs #Novartis #glivec #Section 3(d) #Indian Patent act